Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New MMP inhibitors in early development at Ono

Sep. 23, 1998

Kyowa Hakko studies DC-107 derivatives as antitumor/antibacterial agents

Sep. 23, 1998

Cephalon presents CEP-701 at German cancer meeting

Sep. 22, 1998

Takeda describes preparation and use of inhibitors of steroid C17-20 lyase

Sep. 22, 1998

Procyon receives U.S. patent for the use of ANAs in the treatment of cancer

Sep. 22, 1998

Sugen initiates two new trials with lead compound

Sep. 22, 1998

Gene transfer may be an effective strategy for treatment of AIDS-related Kaposi's sarcoma

Sep. 22, 1998

Spotlight on angiogenesis inhibitors in clinical testing

Sep. 22, 1998

Pacific Pharmaceuticals initiates NCI-sponsored trial at Duke University Medical Center

Sep. 21, 1998

NCI to sponsor pivotal phase III trials of AEterna's Neovastat

Sep. 21, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...